Amit N. Patel, M.D., M.S., director of Cardiovascular Regenerative Medicine at the University of Utah School of Medicine and cardiac surgeon at University of Utah Health Care (right).
3-dimensional electrochemical mapping was used to target ixmyelocel-T cell therapy to damaged areas of hearts in patients with end-stage heart failure.
3-dimensional electrochemical mapping was used to target ixmyelocel-T cell therapy to damaged areas of hearts in patients with end-stage heart failure.